Clinical Trials Browser

INDUSTRY × Lymphoma, Follicular × Clear all

NCT03460977 2026-04-16

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Phase 1 Recruiting

453 enrolled

LymphoidThoracic

Lymphoma, Follicular, Recurrence, Small Cell Lung Carcinoma

NCT06784752 2026-04-16

NETTER-3

Phase 3 Recruiting

240 enrolled

EndocrineGastrointestinalLymphoidNET

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Follicular

NCT04329728 2026-04-15

OPAL

Phase 1/2 Recruiting

144 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoproliferative Disorders, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, T-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05006716 2026-04-15

CaDAnCe-101

Phase 1/2 Recruiting

614 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Clinical Trials

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

NETTER-3

OPAL

CaDAnCe-101

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

SynKIR-310 for Relapsed/Refractory B-NHL

CAN3001

Edwards EVOQUE Eos MISCEND Study

OLYMPIA-5

EPCORE™FL-2

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

EPCORE™ NHL-3

EPCORE™ NHL-2

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

TITANium

LEDA

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

BAF_FRontier-1

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma

A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

MAHOGANY

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Evolut™ EXPAND TAVR II Pivotal Trial

Atalanta-1

MK-2140-006

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

OLYMPIA-1

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation

SIGMA

A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

Aquarius

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

ALPHA

SYMPHONY-1

NEO100 and High-Grade Meningioma

Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies